There is strong relationship exist between obesity and cardiovascular disease including coronary artery disease (CAD). However, better outcomes noted in obese patients undergoing percutaneous cardiovascular interventions for CAD, a phenomenon known as the obesity paradox. In this review, we performed extensive search for obesity paradox in obese patients undergoing percutaneous coronary intervention and discussed possible mechanism and disparities in different race and sex.
INTRODUCTION
Obesity is a condition with body mass index (BMI) more than 30.0 kg/m 2 , accounts for more than one-third of adult United State population with 78.6 million people [1] . It is one of the major burden in health care system [2] and is associated with a increased risk of developing cardiovascular diseases including hypertension, coronary artery disease (CAD), heart failure (HF), and arrhythmias [3] . Obese individuals have increased total blood volume leading to increased work load for the heart which in turn causes high stroke volume, hypertension, left ventricular hypertrophy and dilatation contributing to HF [4] . Obesity is a metabolic syndrome and is associated with co-morbid condition including dyslipidemia and diabetes mellitus. All of these factors contribute to CAD and, in addition, obesity is an independent risk factor for early CA and increases cardiovascular mortality and morbidity. A common strategy of treating CAD is through percutaneous coronary intervention (PCI). Research have shown that obese patients have better outcomes and fewer complications compared to nonobese patients following a PCI, a phenomenon that has been termed as the obesity paradox [5] . In this study, we reviewed the literature to present better understanding of obesity paradox and associated outcomes in cardiovascular disease.
RESEARCH METHODS
We searched PubMed, Ovid, and Google Scholar for English language articles using terms obesity, paradox, percutaneous coronary intervention, coronary artery disease in various combinations. The abstracts were reviewed and articles related to OX and PCI were examined in detail.
OBESITY AND PCI
Obesity is a risk factor for developing cardiovascular disease and is poor prognostic factor for overall mortality [6, 7] . Nevertheless, a phenomenon known as obesity paradox especially in patients undergoing coronary intervention exist, and shows improved overall clinical outcomes including myocardial infarction (MI) and procedural complications [5, [8] [9] [10] [11] [12] [13] (Table 1) .
A systemic review by Gurm et al [14] of four different trial. They analyzed 11300 patients for 30-d morbidity and mortality and 7290 patients for a 12-mo follow-up. They also observed a paradoxical effect in the obese group compared to the low, normal and overweight BMI patients after PCI. The 30-d mortality was statistically significantly lower and similar results were detected in the long-term follow-up.
In a cohort study, Angerås et al [15] analyzed 64436 patients from the Swedish Coronary Angiography and Angioplasty Registry. They divided the patients into two groups based on the significance of CAD and the treatment options (PCI, coronary artery bypass, or medical treatment). These patients were followed for up to 3 years for overall mortality. Their analysis showed a U-shaped mortality curve, with the least mortality in obese and overweight patients compared with normal, underweight, and morbidly obese patients. Hence, this study provides additional evidence of an obesity paradox.
In the Using the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry, Younge et al [16] analyzed 1019 patients who underwent PCI and followed them for 7 years for all-cause mortality to determine the association between health status, BMI, and mortality. They found that the overall mortality was decreased in overweight compared with obese and normal weight patients. Lazzeri et al [17] conducted a retrospective analysis to study the relationship between age and obesity in the outcome of ST-elevation MI (STEMI) in patients treated with primary PCI therapy. The study included 1268 patients who were divided based on their BMI and age. The study had 2.9% patients with a lean BMI, 31.8% with normal, 51.7% with overweight, and 13.6% with an obese BMI, out of which 68.1% were less than 75 years of age and 31.9% were above 75 years of age. All-cause mortality was measured during in-hospital stay and at 1-year follow-up. They concluded that patients with a lean BMI had the highest mortality across all age subgroups at short and longterm follow-ups, and younger obese patients (age < 75 years) showed the lowest mortality only at shortterm follow-up. Their findings indicate that obese populations develop cardiovascular heart disease at a younger age compared with the lean population and therefore, have less all-cause mortality at short-term. They also concluded that the obesity paradox is agerelated because most of the obese individuals included in the study were in the younger age groups and their current medical condition was based on their consistent weight in the obese range. Therefore, with intervention and appropriate weight loss regimen, a majority of the health problems could potentially dissipate with the decrease in the patients' weights. The lowest mortality at short-term observed in the younger obese patients is an expected result because the medical intervention helped them to recover from their medical conditions. Therefore, based on the above findings, it can be inferred that the obesity paradox is related to age in some instances. A study by Akin et al [2] analyzed the relationship between BMIs after PCI with drug-eluding stent (DES). The investigators followed patients who underwent PCI with DES to determine if they had major cardiac, cerebrovascular events (MACCE), such as death, MI, or cerebrovascular accident, and target vessel revascularization (TVR) during their in-hospital stay and at 1-year follow-up. A total of 5806 patients were enrolled in this study, out of which 24.7% had normal BMI, 48.9% were overweight, and 26.4% obese. No difference was observed in overall in-hospital MACCE rate in relation to BMI. However, in-hospital death was noted to be significantly higher in patients with normal BMI compared with overweight and obese patients. At one-year follow-up, there was no significant difference in MACCE-free and TVR-free survival in relation to BMI. It can be concluded that no "obesity paradox" was observed in patients after PCI with DES. Sharma et al [19] conducted a meta-analysis of 36 [2] 1436 normal weight, 2839 overweight, and 1531 obese patients
Retrospective Cohort Study
Primary endpoints were the rate of major adverse cardiac and cerebrovascular events and target vessel revascularization
Baseline clinical parameters were more severe in overweight and obese patients Angerås et al [15] 64436 patients going under angiography. Patients were divided into 9 groups based upon BMI Cohort Study To investigate the relationship between BMI and mortality in patients with ACSs
Obese and overweight patients have least mortality compared with normal, underweight, and morbidly obese patients Gurm et al [14] 4 randomized, controlled trials Systematic Review
To study the impact of BMI on outcome patients undergoing PCI
Increased BMI is associated with reduced risk of complications after PCI Kaneko et al [11] [20] 3076 patients undergoing PCI Case Control Study
In-hospital mortality BMI itself had no impact on in-hospital mortality in patients undergoing primary PCI Sharma et al [19] 36 studies (12 CABG; 26 PCI) Meta-Analysis Total mortality, CV mortality, and myocardial infarction
The risk of total mortality, CV mortality, and MI was highest among underweight patients as defined by low BMI and CV mortality was lowest among overweight patients Stähli et al [9] 1993 Lancefield et al [10] 4762 patients undergoing PCI Meta-Analysis In-hospital and 12-mo MACE and mortality rates after PCI Overweight and obese patients had lower in-hospital and 12-mo MACE and mortality rates after PCI Uretsky et al [5] 22576 hypertensive patients with coronary artery disease
Randomized Control Trial
Primary outcomes include first occurrence of death, nonfatal myocardial infarction, or nonfatal stroke
Obese patients had a decreased risk of primary outcomes
Kang et al [12] 3824 STEMI patients: 129 underweight, 1253 normal weight, 1959 overweight, 483 obese
Retrospective Cohort Study
In-hospital mortality, revascularization in 1 yr, mortality in 1 yr, and overall mortality
Obese patients had significantly lower inhospital and overall mortalities Numasawa et al [13] 10142 patients: 462 underweight, 5945 normal, 3100 overweight and 635 obese
In-hospital outcomes Obese patients are at a lower risk for inhospital complications during and after PCI Younge et al [16] All-cause mortality Overweight, but not obesity, was associated with a lower risk for 7-yr mortality in PCI patients Wang et al [21] 6083 patients (normal: 
MECHANISM OF OBESITY PARADOX
Various mechanisms have been proposed for the observed obesity paradox in coronary heart disease. As BMI increases the size of coronary arteries proportionally increase as well and small coronary artery are associated with worse outcome after PCI and CABG [22] . Obese patients are protected again malnutrition and wastage of energy, therefore cardiac remodeling after MI is greater in obese compared to underweight patients. Obese patients have a high calorie reserve which is beneficial in case cardiovascular disease induces cachexia, a known adverse prognostic factor in HF. Post-procedure cachexia will have a detrimental effect on the patients' overall health [23] . In addition, the obese patients with heart disease are likely to make lifestyle changes that include better diet, caloric restrictions, daily exercise which can positively shift the disease prognosis. Cytokines and hormonal profile is also altered in obesity which can have cardio-protective effect by neutralizing the harmful effects of other biological factors that are up regulated in acute and chronic heart disease. The high levels of the inflammatory TNF-α can be quenched by the high density of TNF-α receptors on the adipose tissues [24] . In addition, obese individuals have been shown to have significantly lower levels of circulating natriuretic peptides, which are associated with HF pathophysiology [25] . The higher levels of free lipoproteins in the obese also help block LPS and other inflammatory cytokines [26] .
GENDER AND RACIAL DISPARITY IN OBESITY PARADOX
A recent cohort study by Vest et al [27] showed that overweight females with HF had a survival advantage compared to overweight males. They reviewed 3811 HF patients and determined the impact of BMI on mortality. When the data was adjusted for potential confounders, the overweight and obese males did not show any significant survival advantage; in the females however, the mortality associated with HF was higher in normal weight group compared to the obese even after the confounding factors were adjusted. An association between race and obesity paradox has also been explored. A retrospective study by Kokkinos et al [28] correlated BMI with mortality in 2013
African-American and 2000 Caucasian males with a mean age 60 years. A correlation was observed between BMI and mortality in the entire cohort, the healthy weight participants had a significantly higher risk, a hazard ratio (HR) of 1.7, compared to the obese subjects. This association was stronger in the AfricanAmerican group (HR 1.95) compared to the Caucasian group (HR 1.53). However, the study was not focused on the obesity paradox specifically among CVD patients as presence of a cardiovascular disease was not studies [12 coronary artery bypass graft (CABG) and 26 PCI] to investigate the relationship of BMI with total mortality, cardiovascular mortality, and MI post-PCI and CABG. They reported that the relative risk of total mortality, cardiovascular mortality, and MI was the highest among patients with low BMI and lowest among overweight patients [19] . In another analysis limited to post-PCI patients, Sharma et al [19] noted that the total mortality, CV mortality, and MI were the highest among patients with low BMI at the end of a mean follow-up period of 1.6 years. The CV mortality was the lowest among overweight patients. The investigators explained that better outcomes in overweight and obese patients could have been influenced by age, as the severely obese patients in the study were younger than the normal-weight patients on average by 7 years for PCI and 4 years for CABG. Because their study was not a randomized trial, patients could have had unmeasured CVD risk factors that affected outcomes. They also reported that in the CABG subgroup, CV mortality was highest among severely obese patients; therefore, they stated that prospective studies were needed to determine associations between weight and outcomes and to explore any underlying mechanisms. Stähli et al [9] assessed long-term mortality of 1993 patients undergoing chronic total occlusion (CTO) PCI at a tertiary care center. They studied patients according to different BMI categories: 23.1% were of normal weight, 49.4% were overweight, 19.9% were obese, and 7.2% were very obese. They found that compared with normal weight BMI patients (16.3%), overweight patients had a lower all-cause mortality (10.2%, logrank P = 0.001), while obese (11.1%, log-rank P = 0.08) and severely obese (13.2%, log-rank P = 0.39) patients had similar mortality rates. Being overweight was significantly associated with lower all-cause mortality. They concluded that overweight is associated with an improved survival in patients undergoing PCI for CTO, particularly in men. Kosuge et al [20] studied 3076 patients to determine the impact of BMI on outcomes after PCI for acute myocardial infarction (AMI). They reported that obese patients had a higher frequency of diabetes mellitus, hyperlipidemia, hypertension and smoking. Wang et al [21] examined 6083 patients who were divided into three groups according to BMI: Normal (n = 1592), overweight (n = 3026), and obese (n = 1465). The follow-up focused on clinical-driven repeat revascularization, including target lesion revascularization (TLR) and non-TLR. There was no significant difference in the incidence of TLR among normal, overweight, and obese patients (6.3% vs 6.1% vs 7.1%, P = 0.423).
In contrast, the incidence of non-TLR was significantly higher in obese patients compared with normal and overweight (8.4% vs 6.0% vs 5.8%, P = 0.003). They concluded that, among patients undergoing PCI with DES, obesity was not associated with TLR but was associated with a higher risk of non-TLR. considered as an inclusion or an exclusion factor for the participants.
LIMITATIONS
The hypothesis of obesity paradox is controversial as the respective studies are limited by various biases and limitations. Most studies on the obesity paradox are retrospective in nature and therefore do not present any evidence of a direct link between obesity and better CAD treatment prognosis. Obese patients with CAD usually present earlier to the clinicians compare to their leaner counterparts. Therefore, the prolonged survival seen in the obese may simply be an earlier detection. There is evidence that the higher blood pressures seen in obese individuals makes them tolerate and respond better to CAD medications [29] . This may be easily confused with an inherent cardio-protective mechanism in the obese. Smoking is a common risk factor for CAD onset and poor prognosis and is most correlated with individuals with leaner BMIs: This could be another reason for a perceived better prognosis in the obese [30] . CAD prognosis is often confounded by the presence of other patho-physiological conditions like cancer [30] . The obesity paradox has been negated in one study that used X-ray absorptiometry to directly assess body fat levels instead of using the BMI index [31] .
CONCLUSION
There is an obesity epidemic and these patients have higher prevalence of co-morbid conditions such as arrhythmia, hypertension, hyperlipidemia, diabetes mellitus, which then increase the risk for CAD. Studies have shown favorable outcome after coronary intervention in obese patients proving phenomenon obesity paradox. There is an also strong disparity between different sex and race for obesity paradox and further studies are needed to investigate these disparities.
